Grouzmann · PloS one 2015 · cross-sectional comparative study and in vitro experiment · n=66 tissue samples, 73 plasma samples

Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?

Cited 36 times in the scientific literature.

Level 4 - case-series / case-control

Cross-sectional comparative human tissue and plasma study with in vitro cell culture experiments.

PubMed 25946206 · doi:10.1371/journal.pone.0125426 · record verified 2026-08-29

What was done

Researchers evaluated the effect of tumor anatomical location on catecholamine metabolism across 66 tissue samples (53 pheochromocytomas [PHEO], 13 paragangliomas [PGL]) and 73 plasma samples (50 PHEO, 23 PGL). Tyrosine hydroxylase (TH), dopamine β-hydroxylase (DBH), and phenylethanolamine N-methyltransferase (PNMT) mRNA and protein expressions were quantified using qPCR and Western blot. PHEOs were partitioned into noradrenergic (intra-tumoral norepinephrine/epinephrine ratio > 90%) and mixed tumors. Primary PHEO and PGL cell cultures were also incubated with dexamethasone for 24 hours to test glucocorticoid-mediated enzymatic regulation.

What was found

Initial comparisons showed significantly lower intra-tumoral concentrations of catecholamines and metanephrines, alongside downregulation of TH and PNMT mRNA and protein in PGL compared to unstratified PHEO (no numeric values or p-values reported in the abstract). When PHEOs were partitioned by catecholamine ratio, noradrenergic PHEOs and PGLs exhibited similar TH, DBH, and PNMT gene and protein expression, as well as equivalent catecholamine concentrations and composition. In primary cell culture, 24-hour dexamethasone treatment increased TH mRNA without altering TH protein expression, and caused no changes in DBH or PNMT mRNA or protein in either tumor type.

Why it matters

This study demonstrates that the microenvironmental glucocorticoid milieu of the adrenal gland does not determine long-term catecholamine synthesis in these tumors. It confirms that biochemical catecholamine and metanephrine profiling cannot distinguish noradrenergic pheochromocytomas from extra-adrenal paragangliomas.

Limits

The study is limited by a small sample size for paragangliomas (13 tissue and 23 plasma samples). The abstract does not provide exact numerical values, effect sizes, or confidence intervals for concentrations and gene/protein expression levels. In vitro testing was limited to a single 24-hour dexamethasone exposure.

Cited by